Latest filing published 22 Jan 2025 for John Hancock CQS Asset Backed Securities Fund, €71.9M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
John Hancock Life Insurance Co USA: trading record in brief
John Hancock Life Insurance Co USA discloses dealings in 3 companies, chiefly InfraREIT, Inc., Manulife Private Credit Plus Fund and John Hancock CQS Asset Backed Securities Fund. In total, 40 filings cover trades dated from 9 March 2015 to 21 January 2025.
On the open market, the record shows 6 purchases worth €81.2M and 33 sales worth €34.5M. The net balance comes to €46.7M on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2025: 2 purchases and no sales on the market.
In size, the median ticket on the buying side is €2.3M. 4 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The record was last updated on 22 January 2025 with an open-market purchase (€71.9M) in John Hancock CQS Asset Backed Securities Fund. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John Hancock Life Insurance Co USA
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,745,000 shares@ US$20.00Class I SharesSEC:0001950731-25-000029:1Canonical exit: 21 Apr 2025 (T+90)
- 5,000 shares@ US$20.00100.0% of flowClass A SharesSEC:0001950731-25-000029:0Canonical exit: 21 Apr 2025 (T+90)
- 98,814 shares@ US$20.2420.0% of flowCommon Shares of Beneficial InterestSEC:0001561793-24-000012:0Canonical exit: 1 May 2024 (T+90)
- 98,765 shares@ US$20.2519.6% of flowCommon Shares of Beneficial InterestSEC:0001950731-24-000004:0Canonical exit: 1 Apr 2024 (T+90)
- 150,075 shares@ US$19.9929.8% of flowCommon Shares of Beneficial InterestSEC:0001561793-23-000039:0Canonical exit: 29 Feb 2024 (T+90)
- 150,000 shares@ US$20.0030.6% of flowCommon Shares of Beneficial InterestSEC:0001561793-23-000032:0Canonical exit: 30 Jan 2024 (T+90)
- 82,633 shares@ US$25.33Common StockSEC:0001145443-15-001133:0
- 100,000 shares@ US$26.33Common StockSEC:0001145443-15-001131:0
- 40,000 shares@ US$26.10Common StockSEC:0001145443-15-001131:1
- 40,000 shares@ US$26.83Common StockSEC:0001145443-15-001129:0
- 30,000 shares@ US$26.86Common StockSEC:0001145443-15-001129:1
- 30,000 shares@ US$27.44Common StockSEC:0001145443-15-001127:0
- 80,000 shares@ US$27.29Common StockSEC:0001145443-15-001127:1
- 8,367 shares@ US$28.44Common StockSEC:0001145443-15-001125:0
- 30,000 shares@ US$28.25Common StockSEC:0001145443-15-001125:1
- 10,000 shares@ US$28.36Common StockSEC:0001145443-15-001119:0
- 50,000 shares@ US$28.40Common StockSEC:0001145443-15-001119:1
- 50,000 shares@ US$28.65Common StockSEC:0001145443-15-001099:0
- 6,000 shares@ US$28.47Common StockSEC:0001145443-15-001099:1
- 17,000 shares@ US$27.85Common StockSEC:0001145443-15-001076:0
- 16,000 shares@ US$27.77Common StockSEC:0001145443-15-001076:1
- 20,000 shares@ US$28.58Common StockSEC:0001145443-15-001068:0
- 20,000 shares@ US$27.72Common StockSEC:0001145443-15-001068:1
- 40,000 shares@ US$28.86Common StockSEC:0001145443-15-001052:0
- 40,000 shares@ US$28.99Common StockSEC:0001145443-15-001052:1
25 of 38 declarations